Suppr超能文献

基于非细胞病变性DNA的库京病毒复制子载体在体外和体内对异源基因的稳定高水平表达。

Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors.

作者信息

Varnavski A N, Young P R, Khromykh A A

机构信息

Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Herston, Brisbane 4029, Australia.

出版信息

J Virol. 2000 May;74(9):4394-403. doi: 10.1128/jvi.74.9.4394-4403.2000.

Abstract

Primary features of the flavivirus Kunjin (KUN) subgenomic replicons include continuous noncytopathic replication in host cell cytoplasm and the ability to be encapsidated into secreted virus-like particles (VLPs). Previously we reported preparation of RNA-based KUN replicon vectors and expression of heterologous genes (HG) in cell culture after RNA transfection or after infection with recombinant KUN VLPs (A. N. Varnavski and A. A. Khromykh, Virology 255:366-375, 1999). In this study we describe the development of the next generation of KUN replicon vectors, which allow synthesis of replicon RNA in vivo from corresponding plasmid DNAs. These DNA-based vectors were able to direct stable expression of beta-galactosidase (beta-Gal) in several mammalian cell lines, and expression remained high ( approximately 150 pg per cell) throughout cell passaging. The applicability of these vectors in vivo was demonstrated by beta-Gal expression in the mouse lung epithelium for at least 8 weeks after intranasal inoculation and induction of anti-beta-Gal antibody response after intramuscular inoculation of the beta-Gal-encoding KUN replicon DNA. The noncytopathic nature of DNA-based KUN replicon vectors combined with high-level and stability of HG expression in a broad range of host cells should prove them to be useful in a variety of applications in vitro and in vivo.

摘要

黄病毒库京(KUN)亚基因组复制子的主要特征包括在宿主细胞质中持续进行非细胞病变性复制,以及被包装进分泌性病毒样颗粒(VLP)的能力。此前我们报道了基于RNA的KUN复制子载体的制备以及RNA转染后或用重组KUN VLP感染后异源基因(HG)在细胞培养中的表达(A. N. 瓦尔纳夫斯基和A. A. 赫罗梅赫,《病毒学》255:366 - 375,1999)。在本研究中,我们描述了下一代KUN复制子载体的开发,该载体能够在体内从相应的质粒DNA合成复制子RNA。这些基于DNA的载体能够在几种哺乳动物细胞系中指导β - 半乳糖苷酶(β - Gal)的稳定表达,并且在整个细胞传代过程中表达水平保持较高(约每细胞150 pg)。通过鼻内接种后在小鼠肺上皮中β - Gal表达至少8周以及肌肉接种编码β - Gal的KUN复制子DNA后诱导抗β - Gal抗体反应,证明了这些载体在体内的适用性。基于DNA的KUN复制子载体的非细胞病变性质,结合其在广泛宿主细胞中HG表达的高水平和稳定性,应证明它们在体外和体内的各种应用中是有用的。

相似文献

4
Tetracycline-inducible packaging cell line for production of flavivirus replicon particles.
J Virol. 2004 Jan;78(1):531-8. doi: 10.1128/jvi.78.1.531-538.2004.
7
Subgenomic replicons of the flavivirus Kunjin: construction and applications.
J Virol. 1997 Feb;71(2):1497-505. doi: 10.1128/JVI.71.2.1497-1505.1997.
9
Kunjin virus replicon vectors for human immunodeficiency virus vaccine development.
J Virol. 2003 Jul;77(14):7796-803. doi: 10.1128/jvi.77.14.7796-7803.2003.

引用本文的文献

1
Development of a reverse genetics system for West Nile virus (Kunjin type).
Front Vet Sci. 2025 Aug 25;12:1671591. doi: 10.3389/fvets.2025.1671591. eCollection 2025.
5
Application of DNA Replicons in Gene Therapy and Vaccine Development.
Pharmaceutics. 2023 Mar 15;15(3):947. doi: 10.3390/pharmaceutics15030947.
8
Therapeutic vaccines for high-risk HPV-associated diseases.
Papillomavirus Res. 2018 Jun;5:46-58. doi: 10.1016/j.pvr.2017.12.006. Epub 2017 Dec 19.
10
Perspectives for therapeutic HPV vaccine development.
J Biomed Sci. 2016 Nov 4;23(1):75. doi: 10.1186/s12929-016-0293-9.

本文引用的文献

1
Induction and maintenance of autonomous flock house virus RNA1 replication.
J Virol. 1999 Oct;73(10):7933-42. doi: 10.1128/JVI.73.10.7933-7942.1999.
2
Cancer therapy using a self-replicating RNA vaccine.
Nat Med. 1999 Jul;5(7):823-7. doi: 10.1038/10548.
3
Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells.
J Virol. 1999 May;73(5):3854-65. doi: 10.1128/JVI.73.5.3854-3865.1999.
5
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression.
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12989-94. doi: 10.1073/pnas.95.22.12989.
6
RNA virus vectors: where are we and where do we need to go?
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12750-2. doi: 10.1073/pnas.95.22.12750.
8
Rapid, high level protein production using DNA-based Semliki Forest virus vectors.
J Biol Chem. 1998 Jul 17;273(29):18060-6. doi: 10.1074/jbc.273.29.18060.
10
Enhancing immune responses using suicidal DNA vaccines.
Nat Biotechnol. 1998 Jun;16(6):562-5. doi: 10.1038/nbt0698-562.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验